Free Trial

Monopar Therapeutics (MNPR) SEC Filings & 10K Form

$0.61
-0.01 (-1.61%)
(As of 05/21/2024 ET)

Recent Monopar Therapeutics SEC Filings

DateFilerForm TypeView
05/09/2024
6:00 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
6:00 AM
Monopar Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/16/2024
7:00 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2024
7:00 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2024
7:33 PM
Monopar Therapeutics (Issuer)
Robinson Chandler (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
7:33 PM
Monopar Therapeutics (Issuer)
Tsuchimoto Kim R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
7:35 PM
Cittadine Andrew (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
6:00 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2024
6:01 AM
Monopar Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/07/2024
7:30 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2024
6:00 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2024
12:45 PM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2024
5:59 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/22/2024
6:00 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2024
7:00 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2024
6:36 PM
Monopar Therapeutics (Issuer)
Robinson Chandler (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
6:37 PM
Monopar Therapeutics (Issuer)
STARR CHRISTOPHER M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
6:38 PM
KLAUSNER ARTHUR J (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
6:39 PM
Cittadine Andrew (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
6:40 PM
Brown Michael J (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
6:40 PM
Anderson Raymond (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
6:33 PM
Monopar Therapeutics (Issuer)
RIOUX PATRICE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
6:34 PM
Monopar Therapeutics (Issuer)
Tsuchimoto Kim R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/09/2023
6:00 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2023
6:01 AM
Monopar Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/01/2023
6:00 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2023
6:35 PM
Monopar Therapeutics (Issuer)
STARR CHRISTOPHER M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2023
6:36 PM
Monopar Therapeutics (Issuer)
Tsuchimoto Kim R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2023
6:37 PM
Monopar Therapeutics (Issuer)
Robinson Chandler (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2023
6:30 PM
Cittadine Andrew (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2023
6:31 PM
Anderson Raymond (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2023
6:32 PM
Brown Michael J (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2023
6:34 PM
KLAUSNER ARTHUR J (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2023
4:16 PM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/10/2023
6:00 AM
Monopar Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/10/2023
6:00 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2023
6:00 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/11/2023
6:00 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2023
5:45 PM
Monopar Therapeutics (Issuer)
Robinson Chandler (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2023
5:46 PM
Monopar Therapeutics (Issuer)
Tsuchimoto Kim R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2023
5:46 PM
Monopar Therapeutics (Issuer)
STARR CHRISTOPHER M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (Ad)

Are you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealthy beyond your wildest dreams. You see, while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls.

Claim your free seat by clicking here now.
07/03/2023
5:49 PM
KLAUSNER ARTHUR J (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2023
5:49 PM
Brown Michael J (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2023
5:50 PM
Anderson Raymond (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2023
5:51 PM
Cittadine Andrew (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2023
6:01 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:MNPR) was last updated on 5/21/2024 by MarketBeat.com Staff

From Our Partners